Neostigmine Methylsulfate Injection, Solution
Product Images NDC 63323-415

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 63323-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Neo0n 0000 01

Neo0n 0000 01
FDA Label Image

Neo0n 0000 02

Neo0n 0000 02
FDA Label Image

Neo0n 0000 03

Neo0n 0000 03
FDA Label Image

Neo0n 0000 04

Neo0n 0000 04
This description is not available.*
FDA Label Image

Neo0n 0000 05

Neo0n 0000 05
FDA Label Image

Neo0n 0000 06

Neo0n 0000 06
This is a description of Neostigmine Methylsulfate Injection, USP, in a concentration of 10 mg per 10 mL for intravenous use. The product comes in 16 x 16 mL multiple-dose vials and is available by prescription only under the brand PREMIERProRx®.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.